Illumina Stock Investor Sentiment

ILMN Stock  USD 140.14  3.15  2.30%   
About 56% of all Illumina's investors are looking to take a long position. The analysis of overall sentiment of trading Illumina stock suggests that some investors are interested at this time. Illumina's investing sentiment overview a quick insight into current market opportunities from investing in Illumina. Many technical investors use Illumina stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

56

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Illumina's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Illumina.

Illumina Historical Sentiment

Although Illumina's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Illumina, such as negative comments on social media and news outlets, may cause fear in the market and push Illumina's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Illumina.
  

Illumina Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Illumina can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Illumina Historical Investor Sentiment

Investor biases related to Illumina's public news can be used to forecast risks associated with an investment in Illumina. The trend in average sentiment can be used to explain how an investor holding Illumina can time the market purely based on public headlines and social activities around Illumina. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Illumina's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Illumina and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Illumina news discussions. The higher the estimate score, the more favorable the investor's outlook on Illumina.
over a month ago at investing.com         
Grail CEO Robert Ragusa sells 1.73 million in stock
Investing News at Macroaxis
over a month ago at finance.yahoo.com         
Is this the Best Time to Add Illumina?
Yahoo News
over a month ago at benzinga.com         
100 Invested In This Stock 20 Years Ago Would Be Worth 4,600 Today
benzinga news
over a month ago at benzinga.com         
Smart Money Is Betting Big In ILMN Options
benzinga news
over a month ago at investors.com         
Illumina Hits 80-Plus Relative Strength Rating Benchmark
Investors Business Daily at Macroaxis
over a month ago at gurufocus.com         
Illumina Inc Shares Up 3.08 percent on Oct 14
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
MYGN Taps Ultima Genomics UG 100 Platform for Advanced Clinical Tests
Yahoo News
over a month ago at statnews.com         
A crack of light for Pfizer
news
over a month ago at finance.yahoo.com         
Clinical Oncology Next-Generation Sequencing Market Set for Explosive Growth, Projected to Reach USD...
Yahoo News
over a month ago at seekingalpha.com         
Illumina introduces new DNA sequencing instruments, but Street unimpressed
seekingalpha News
over a month ago at finance.yahoo.com         
Illumina introduces the MiSeq i100 Series its simplest, fastest benchtop sequencers
Yahoo News
over a month ago at businesswire.com         
Inocras Unveils Breakthrough Study, Proving Target-Enhanced Whole-Genome Sequencing Outperforms Stan...
businesswire News
over a month ago at finance.yahoo.com         
Inocras Unveils Breakthrough Study, Proving Target-Enhanced Whole-Genome Sequencing Outperforms Stan...
Yahoo News
over a month ago at businesswire.com         
Inocras Unveils Breakthrough Study, Proving Target-Enhanced Whole-Genome Sequencing Outperforms Stan...
businesswire News
over a month ago at zacks.com         
Heres Why Illumina is a Strong Momentum Stock
zacks News
Far too much social signal, news, headlines, and media speculation about Illumina that are available to investors today. That information is available publicly through Illumina media outlets and privately through word of mouth or via Illumina internal channels. However, regardless of the origin, that massive amount of Illumina data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Illumina news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Illumina relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Illumina's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Illumina alpha.

Illumina Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Jacob Thaysen of 7426 shares of Illumina subject to Rule 16b-3
09/20/2024
2
Disposition of 914 shares by Jacob Thaysen of Illumina at 140.66 subject to Rule 16b-3
10/04/2024
3
Earnings call Standard BioTools faces mixed Q3 results amid market challenges
10/31/2024
4
Vanguard Group Incs Strategic Acquisition of Illumina Inc Shares
11/05/2024
5
Heres Why You Should Invest in Illumina
11/08/2024
6
Illumina, Inc. Unlocking Growth Potential in Genetic Testing and Robotics
11/12/2024
7
Illumina, Inc. Given Average Rating of Moderate Buy by Analysts
11/13/2024
8
10,563 Shares in Illumina, Inc. Bought by Entropy Technologies LP
11/14/2024
9
Is Illumina, Inc. the Best Immunotherapy Stock to Buy Now
11/18/2024
10
1,715 Shares in Illumina, Inc. Bought by Cassaday Co Wealth Management LLC
11/19/2024
11
NS Partners Ltd Buys 900 Shares of Illumina, Inc.
11/20/2024
12
Connor Clark Lunn Investment Management Ltd. Purchases 114,466 Shares of Illumina, Inc.
11/21/2024
When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.96)
Earnings Share
(9.96)
Revenue Per Share
27.654
Quarterly Revenue Growth
(0.04)
Return On Assets
0.0262
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.